Fibrocell Science, Inc. (FCSC) was a big mover last session, as its shares rose over 14% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend for the company, as the stock is now trading above the volatile price range of $2.76 to $3.15 in the past one-month timeframe.
In the last 30 days, the company witnessed one negative estimate revision and the Zacks Consensus Estimate also moved lower, suggesting trouble down the road. So make sure to keep an eye on this stock going forward to see if yesterday's move higher lasts.
Fibrocell Science currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Other better-ranked stocks in the medical sector include Gilead Sciences Inc. GILD, ANI Pharmaceuticals, Inc. ANIP and Illumina Inc. ILMN. All three sport a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
ILLUMINA INC ILMN: Free Stock Analysis Report
ANI PHARMACEUT ANIP: Free Stock Analysis Report
GILEAD SCIENCES GILD: Free Stock Analysis Report
FIBROCELL SCIEN (FCSC): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
Market News and Data brought to you by Benzinga APIsIn the last 30 days, the company witnessed one negative estimate revision and the Zacks Consensus Estimate also moved lower, suggesting trouble down the road. So make sure to keep an eye on this stock going forward to see if yesterday's move higher lasts.
Fibrocell Science currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Other better-ranked stocks in the medical sector include Gilead Sciences Inc. GILD, ANI Pharmaceuticals, Inc. ANIP and Illumina Inc. ILMN. All three sport a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
ILLUMINA INC ILMN: Free Stock Analysis Report
ANI PHARMACEUT ANIP: Free Stock Analysis Report
GILEAD SCIENCES GILD: Free Stock Analysis Report
FIBROCELL SCIEN (FCSC): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
